Last updated: 2026-09-09 05:11:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Lexicon Pharmaceuticals, Inc. (LXRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.23, with a market capitalization of $996.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.05 to $2.68. This page covers its latest market performance, valuation, price trends and company information.
$996.70M | |
$2.22 | |
$28.21 | |
$0.28 | |
$2.24 | |
1.36M | |
3.32M | |
-- | |
$2.68 | |
$1.05 | |
-- | |
-- |
Lexicon Pharmaceuticals, Inc. (LXRX) last closed at $2.24 as of 2026-09-08 23:45:00, unchanged from the previous close of $2.24.
During the latest regular trading session, LXRX traded between $0.28 and $28.21, with a volume of 1.36M shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Lexicon Pharmaceuticals, Inc. (LXRX) moved from $2.32 to $2.23, representing a decline of 4.09% ($0.09).
The stock traded between $2.17 and $2.34 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 2.55 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 72.1%
LXRX is currently trading at $2.23, placing it 72.1% of the way from its 52-week low of $1.05 to its 52-week high of $2.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 81 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Lexicon Pharmaceuticals, Inc. (LXRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.